Projects per year
Abstract
Maintenance of tissue boundaries is crucial for control of metastasis. We describe a novel signalling pathway in which epithelial cell disruption can be minimised and thereby restricts epithelial-mesenchymal transgressions. This involves IGFBP-5 release from apoptotic cells, which increases epithelial cell adhesion on mesenchymal but not epithelial ECM and involves direct interaction of IGFBP-5 with α2β1 integrins. IGFBP-5 also induced adhesion to vitronectin in the absence of αVβ3 integrin, the vitronectin receptor, again via an α2β1 integrin-dependent action, suggesting that IGFBP-5 can induce spreading on matrices, even in the absence of the integrins normally used. Using IGFBP-5 mutants we demonstrate that the effect is IGF-independent but requires the heparin-binding domain in the c-terminus of IGFBP-5. A truncated c-terminal mutant of IGFBP-5 also induced adhesion. Adhesion induced by IGFBP-5 was cdc42-dependent and resulted in activation of ILK and Akt. Consistent with these changes, IGFBP-5 facilitated prolonged cell survival in nutrient-poor conditions and decreased phosphorylation of the stress-activated kinase p38MAPK. Whilst IGFBP-5 enhanced adhesion, it inhibited cell migration although this was not evident using the truncated c-terminal mutant, suggesting that effects of IGFBP-5 on adhesion and migration involve different mechanisms. These responses to IGFBP-5 would be anticipated to reduce metastatic potential.
Original language | English |
---|---|
Pages (from-to) | 1693-1705 |
Number of pages | 13 |
Journal | Journal of Cell Science |
Volume | 125 |
Issue number | 7 |
Early online date | 10 Feb 2012 |
DOIs | |
Publication status | Published - Apr 2012 |
Keywords
- cells
- cell migration
- breast cancer cells
- breast cancer
Fingerprint
Dive into the research topics of 'IGFBP5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells'. Together they form a unique fingerprint.Projects
- 1 Finished
-
IGFBP-5 AND BREAST CANCER RISK
Flint, D. & Allan, G.
BBSRC (Biotech & Biological Sciences Research Council)
1/10/07 → 31/12/10
Project: Research